A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy

Acquired chemotherapy resistance is a major contributor to treatment failure in oncology. For example, the efficacy of the common anticancer agent doxorubicin (DOX) is limited by the emergence of multidrug resistance (MDR) phenotype in cancer cells. While dose escalation of DOX can circumvent such r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Pramanik, Dipankar, Campbell, Nathaniel R., Das, Samarjit, Gupta, Sonal, Chenna, Venugopal, Bisht, Savita, Sysa-Shah, Polina, Bedja, Djahida, Karikari, Collins, Steenbergen, Charles, Gabrielson, Kathleen L., Maitra, Amarnath, Maitra, Anirban
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2012
Assuntos:
Research Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3442295/
https://ncbi.nlm.nih.gov/pubmed/22791660
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados